受强制性开放获取政策约束的文章 - Carlo R. Largiadèr了解详情
无法在其他位置公开访问的文章：13 篇
Clinical importance of risk variants in the dihydropyrimidine dehydrogenase gene for the prediction of early‐onset fluoropyrimidine toxicity
TK Froehlich, U Amstutz, S Aebi, M Joerger, CR Largiadèr
International journal of cancer 136 (3), 730-739, 2015
强制性开放获取政策： Swiss National Science Foundation
Allopurinol hypersensitivity is primarily mediated by dose‐dependent oxypurinol‐specific T cell response
J Yun, J Mattsson, K Schnyder, S Fontana, CR Largiadèr, WJ Pichler, ...
Clinical & Experimental Allergy 43 (11), 1246-1255, 2013
强制性开放获取政策： Swiss National Science Foundation
LC‐MS/MS method for simultaneous analysis of uracil, 5, 6‐dihydrouracil, 5‐fluorouracil and 5‐fluoro‐5, 6‐dihydrouracil in human plasma for therapeutic drug monitoring and …
B Büchel, P Rhyn, S Schürch, C Bühr, U Amstutz, C R. Largiadèr
Biomedical Chromatography 27 (1), 7-16, 2013
强制性开放获取政策： Swiss National Science Foundation
Predicting 5-fluorouracil toxicity: DPD genotype and 5, 6-dihydrouracil: uracil ratio
J Sistonen, B Büchel, TK Froehlich, D Kummer, S Fontana, M Joerger, ...
Pharmacogenomics 15 (13), 1653-1666, 2014
强制性开放获取政策： Swiss National Science Foundation
Novel genetic variants in carboxylesterase 1 predict severe early‐onset capecitabine‐related toxicity
S Hamzic, D Kummer, S Milesi, D Mueller, M Joerger, S Aebi, U Amstutz, ...
Clinical Pharmacology & Therapeutics 102 (5), 796-804, 2017
强制性开放获取政策： Swiss National Science Foundation
How normal is abnormal? Discrimination between deformations and natural variation in gonad morphology of European whitefish Coregonus lavaretus
D Bittner, D Bernet, T Wahli, H Segner, C Küng, CR Largiadèr
Journal of fish biology 74 (7), 1594-1614, 2009
强制性开放获取政策： Swiss National Science Foundation
Purification, cDNA structure and biological significance of a single insulin-like growth factor-binding domain protein (SIBD-1) identified in the hemocytes of the spider …
L Kuhn-Nentwig, CR Largiadèr, K Streitberger, S Chandru, T Baumann, ...
Insect biochemistry and molecular biology 41 (11), 891-901, 2011
强制性开放获取政策： Swiss National Science Foundation
Bevacizumab, pemetrexed, and cisplatin, or bevacizumab and erlotinib for patients with advanced non–small-cell lung cancer stratified by epidermal growth factor receptor …
O Gautschi, N Mach, SI Rothschild, Q Li, RA Stahel, A Zippelius, ...
Clinical lung cancer 16 (5), 358-365, 2015
强制性开放获取政策： Swiss Cancer League
Dihydropyrimidinase and β-ureidopropionase gene variation and severe fluoropyrimidine-related toxicity
D Kummer, TK Froehlich, M Joerger, S Aebi, J Sistonen, U Amstutz, ...
Pharmacogenomics 16 (12), 1367-1377, 2015
强制性开放获取政策： Swiss National Science Foundation
A new DPYD genotyping assay for improving the safety of 5-fluorouracil therapy
J Sistonen, C Smith, YK Fu, CR Largiadèr
Clinica Chimica Acta 414, 109-111, 2012
强制性开放获取政策： Swiss National Science Foundation
Influence of CYP3A5 genetic variation on everolimus maintenance dosing after cardiac transplantation
D Lesche, V Sigurdardottir, R Setoud, L Englberger, GM Fiedler, ...
Clinical transplantation 29 (12), 1213-1220, 2015
强制性开放获取政策： Swiss National Science Foundation
The impact of ABCC11 polymorphisms on the risk of early-onset fluoropyrimidine toxicity
S Hamzic, N Wenger, TK Froehlich, M Joerger, S Aebi, CR Largiadèr, ...
The pharmacogenomics journal 17 (4), 319-324, 2017
强制性开放获取政策： Swiss National Science Foundation
SNPs and Haplotypes in DPYD and Outcome of Capecitabine–Letter
ABP van Kuilenburg, CR Largiadèr
Clinical cancer research 17 (17), 5837-5837, 2011
强制性开放获取政策： US National Institutes of Health
可在其他位置公开访问的文章：40 篇
Clinical relevance of DPYD variants c. 1679T> G, c. 1236G> A/HapB3, and c. 1601G> A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta …
D Meulendijks, LM Henricks, GS Sonke, MJ Deenen, TK Froehlich, ...
The Lancet Oncology 16 (16), 1639-1650, 2015
强制性开放获取政策： Cancer Research UK
Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity
U Amstutz, TK Froehlich, CR Largiadèr
Pharmacogenomics 12 (9), 1321-1336, 2011
强制性开放获取政策： Swiss National Science Foundation
Dihydropyrimidine dehydrogenase gene variation and severe 5-fluorouracil toxicity: a haplotype assessment
U Amstutz, S Farese, S Aebi, CR Largiader
Pharmacogenomics 10 (6), 931-944, 2009
强制性开放获取政策： Swiss National Science Foundation
The international hereditary thrombotic thrombocytopenic purpura registry: key findings at enrollment until 2017
HA van Dorland, MM Taleghani, K Sakai, KD Friedman, JN George, ...
Haematologica 104 (10), 2107, 2019
强制性开放获取政策： Swiss National Science Foundation, US National Institutes of Health
Gender-specific elimination of continuous-infusional 5-fluorouracil in patients with gastrointestinal malignancies: results from a prospective population pharmacokinetic study
F Müller, B Büchel, D Köberle, S Schürch, B Pfister, S Krähenbühl, ...
Cancer chemotherapy and pharmacology 71, 361-370, 2013
强制性开放获取政策： Swiss National Science Foundation
Colonization history of the Swiss Rhine basin by the bullhead (Cottus gobio): inference under a Bayesian spatially explicit framework
S Neuenschwander, CR Largiader, N Ray, M Currat, P Vonlanthen, ...
Molecular Ecology 17 (3), 757-772, 2008
强制性开放获取政策： Swiss National Science Foundation
Dihydropyrimidine dehydrogenase testing prior to treatment with 5-fluorouracil, capecitabine, and tegafur: a consensus paper
B Wörmann, C Bokemeyer, T Burmeister, CH Köhne, M Schwab, D Arnold, ...
Oncology research and treatment 43 (11), 628-636, 2020
强制性开放获取政策： German Research Foundation
出版信息和资助信息由计算机程序自动确定